Wiinberg Ulf's Form 4 filing
MiNK Therapeutics, Inc. (INKT) · filed Jul 21, 2022
- Accession no.
- 0000899243-22-026460
- Filed
- Jul 21, 2022
- Trade date
- Jul 18-19, 2022
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $27.6K. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wiinberg UlfCIK 0001187314 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 18, 2022 | Common Stock | PPurchaseAcquired | +3,339 | $1.33 | +$4,440.87 | 281,639 | Direct | |
| Jul 19, 2022 | Common Stock | PPurchaseAcquired | +16,661 | $1.39 | +$23,158.79 | 298,300 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.